A4Z

2-(4-butoxyphenyl)-N-hydroxyacetamide

Find entries where: A4Z

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	2-(4-butoxyphenyl)-N-hydroxyacetamide
Identifiers	2-(4-butoxyphenyl)-N-oxidanyl-ethanamide
Formula	C₁₂ H₁₇ N O₃
Molecular Weight	223.268
Type	NON-POLYMER
Isomeric SMILES	CCCCOc1ccc(cc1)CC(=O)NO
InChI	InChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)
InChIKey	MXJWRABVEGLYDG-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	33
Chiral Atom Count	0
Bond Count	33
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB13346
Name	Bufexamac
Groups	approved withdrawn
Description	Bufexamac is a non-steroidal anti-inflammatory drug (NSAID) under the market name Droxaryl, Malipuran, Paraderm and Parfenac. It is typically administered topically for the treatment of subacute and chronic eczema of the skin, including atopic eczema and other inflammatory dermatoses, as well as sunburn and other minor burns, and itching. It has also been used in suppositories in combination with local anaesthetics indicated for haemorrhoids. The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822]. Bufexamac was also withdrawn by the EMA in April 2010.
Synonyms	bufexamacum 4-Butoxyphenylacetohydroxamic acid 2-(p-Butoxyphenyl)-acetohydroxamic acid Acide p-butoxyphenylacethydroxamique Bufexamic acid p-Butoxyphenylacetohydroxamic acid Bufexamac 4-Butoxy-N-hydroxybenzeneacetamide bufexamaco
Brand Names	Norfemac Ointment - 5% Norfemac Cream - 5%
Indication	Indicated for the treatment of various skin conditions, such as atopic eczema and other inflammatory dermatoses.
Categories	Acetamides Acetic Acid Derivatives and Related Substances Agents causing hyperkalemia Amides Amines Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal (Non-Selective) Antiinflammatory and Antirheumatic Products Antiinflammatory and Antirheumatic Products, Non-Steroids Antiinflammatory Preparations, Non-Steroids for Topical Use Antineoplastic Agents Antirheumatic Agents Benzene Derivatives Benzeneacetamides Histone Deacetylase Inhibitors Hydroxamic Acids Hydroxy Acids Hydroxylamines Musculo-Skeletal System Nephrotoxic agents Non COX-2 selective NSAIDS Peripheral Nervous System Agents Sensory System Agents Topical Products for Joint and Muscular Pain
ATC-Code	M01AB17 M02AA09
CAS number	2438-72-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Prostaglandin G/H synthase 1	MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...	unknown	inhibitor
Prostaglandin G/H synthase 2	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...	unknown	inhibitor
Histone deacetylase 6	MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEV...	unknown	inhibitor
Histone deacetylase 10	MGTALVYHEDMTATRLLWDDPECEIERPERLTAALDRLRQRGLEQRCLRL...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682